Christopher Michael Cashman - Net Worth and Insider Trading
Christopher Michael Cashman Net Worth
The estimated net worth of Christopher Michael Cashman is at least $94,705 dollars as of 2024-09-20. Christopher Michael Cashman is the CEO of Marinus Pharmaceuticals Inc and owns about 59,940 shares of Marinus Pharmaceuticals Inc (MRNS) stock worth over $94,705. Details can be seen in Christopher Michael Cashman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Michael Cashman has not made any transactions after 2019-01-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Michael Cashman
Christopher Michael Cashman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Michael Cashman owns 1 companies in total, including Marinus Pharmaceuticals Inc (MRNS) .
Click here to see the complete history of Christopher Michael Cashman’s form 4 insider trades.
Insider Ownership Summary of Christopher Michael Cashman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRNS | Marinus Pharmaceuticals Inc | 2019-01-28 | director & President and CEO |
Christopher Michael Cashman Latest Holdings Summary
Christopher Michael Cashman currently owns a total of 1 stock. Christopher Michael Cashman owns 59,940 shares of Marinus Pharmaceuticals Inc (MRNS) as of January 28, 2019, with a value of $94,705.
Latest Holdings of Christopher Michael Cashman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRNS | Marinus Pharmaceuticals Inc | 2019-01-28 | 59,940 | 1.58 | 94,705 |
Holding Weightings of Christopher Michael Cashman
Christopher Michael Cashman Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Michael Cashman has made a total of 0 transactions in Marinus Pharmaceuticals Inc (MRNS) over the past 5 years. The most-recent trade in Marinus Pharmaceuticals Inc is the sale of 2,036 shares on January 28, 2019, which brought Christopher Michael Cashman around $25,485.
Insider Trading History of Christopher Michael Cashman
- 1
Christopher Michael Cashman Trading Performance
GuruFocus tracks the stock performance after each of Christopher Michael Cashman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Michael Cashman is -5.84%. GuruFocus also compares Christopher Michael Cashman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Michael Cashman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Michael Cashman's insider trading performs compared to the benchmark.
Performance of Christopher Michael Cashman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.68 | | | | | |
| Relative Return to S&P 500(%) | 12.04 | | | | | |
Christopher Michael Cashman Ownership Network
Christopher Michael Cashman Owned Company Details
What does Marinus Pharmaceuticals Inc do?
Who are the key executives at Marinus Pharmaceuticals Inc?
Christopher Michael Cashman is the director & President and CEO of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .
Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary
Over the past 18 months, Christopher Michael Cashman made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .
In summary, during the past 3 months, insiders sold 29,071 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 29,071 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.
Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Marinus Pharmaceuticals Inc Insider Transactions
Christopher Michael Cashman Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Michael Cashman. You might contact Christopher Michael Cashman via mailing address: 142 Temple Street, Suite 205, New Haven Ct 06510.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
